Luke Corning serves as Executive at Poseida Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Luke Corning has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 17, 2024 involved receiving (via award) 19,650 shares valued at $0.
Luke Corning currently holds 58,950 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Luke Corning has been a net neutral trader of PSTX stock. They have purchased $0 and sold $0 worth of shares.
Luke Corning's most recent insider trade was on Jun 17, 2024, when they sold 19,650 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 16, 2022 | PSTX | $0 | Award | 19,650 | $N/A | Discretionary |